{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:07:01Z","timestamp":1791810421343,"version":"4.3.4"},"reference-count":53,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["62\/2022"],"award-info":[{"award-number":["62\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background\/Objectives: Tuberculosis (TB) remains a major global health issue, further complicated by the COVID-19 pandemic. This study assesses the clinical outcomes of TB-COVID-19-coinfected patients compared to those with TB disease alone at an Italian infectious disease hospital during the pandemic\u2019s first two years. Methods: Retrospective data analysis was conducted on TB patients hospitalized from March 2020 to June 2022. Data included demographics, comorbidities, clinical characteristics, and outcomes. Coinfection was defined as concurrent TB disease and SARS-CoV-2 infection. Statistical methods included Fisher\u2019s exact test and Mann\u2013Whitney statistics. Results: Of 267 TB patients, 25 (9.4%) had concurrent COVID-19 infection. The TB-COVID-19 group showed higher rates of diabetes and cough. Acute respiratory failure was more prevalent in coinfected patients (odds ratio, 5.99), and coinfection was associated with worse outcomes compared to TB alone (odds ratio, 0.15). Despite similar socio-demographic factors, the coexistence of TB and COVID-19 led to exacerbated respiratory failure and increased mortality. Conclusions: Coinfection with TB and COVID-19 significantly increases the risk of acute respiratory failure and poor outcomes. Clinicians should be aware of this risk, especially in patients with pulmonary involvement. Although specific protocols are unavailable, prompt diagnosis and management may enhance outcomes. Additional research is necessary to understand the long-term effects of TB-COVID-19 coinfection, particularly as COVID-19 becomes endemic.<\/jats:p>","DOI":"10.3390\/idr17010011","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:15:41Z","timestamp":1738728941000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-9705","authenticated-orcid":false,"given":"Virginia","family":"Di Bari","sequence":"first","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Cerva","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Libertone","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Maria","family":"Carli","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Musso","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4376","authenticated-orcid":false,"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[{"name":"Translational Research Unit, National Institute for Infectious Diseases (INMI) \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-9383","authenticated-orcid":false,"given":"Alessandra","family":"Aiello","sequence":"additional","affiliation":[{"name":"Translational Research Unit, National Institute for Infectious Diseases (INMI) \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-4368","authenticated-orcid":false,"given":"Antonio","family":"Mazzarelli","sequence":"additional","affiliation":[{"name":"Microbiology and Bio-Repository, National Institute for Infectious Diseases (INMI) \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cannas","sequence":"additional","affiliation":[{"name":"Microbiology and Bio-Repository, National Institute for Infectious Diseases (INMI) \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-4243","authenticated-orcid":false,"given":"Giulia","family":"Matusali","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-6291","authenticated-orcid":false,"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Gualano","sequence":"additional","affiliation":[{"name":"Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the TB-INMI Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, World Health Organization."},{"key":"ref_2","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS) (2024, November 18). Epidemiologia della Tubercolosi. Available online: https:\/\/www.epicentro.iss.it\/tubercolosi\/epidemiologia."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"NEJM"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: Retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_6","unstructured":"World Health Organization (2024, November 18). Global Excess Deaths Associated with COVID-19, January 2020\u2013December 2021. Available online: https:\/\/www.who.int\/data\/stories\/global-excess-deaths-associated-with-covid-19-january-2020-december-2021."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3201\/eid2611.203163","article-title":"Worldwide effects of coronavirus disease pandemic on tuberculosis services, January\u2013April 2020","volume":"26","author":"Migliori","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5588\/ijtld.21.0148","article-title":"The impact of COVID-19 on TB: A review of the data","volume":"25","author":"McQuaid","year":"2021","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2001718","DOI":"10.1183\/13993003.01718-2020","article-title":"The potential impact of COVID-19-related disruption on tuberculosis burden","volume":"56","author":"McQuaid","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2101786","DOI":"10.1183\/13993003.01786-2021","article-title":"Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study","volume":"58","author":"Migliori","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pulmoe.2020.05.002","article-title":"Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts","volume":"26","author":"Motta","year":"2020","journal-title":"Pulmonology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2100564","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100564","article-title":"Time to regain lost ground: Tuberculosis in the COVID-19 era","volume":"26","author":"Zenner","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ijid.2023.02.025","article-title":"Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study","volume":"130","author":"Nalunjogi","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2001727","DOI":"10.1183\/13993003.01727-2020","article-title":"Epidemic and pandemic viral infections: Impact on tuberculosis and the lung","volume":"56","author":"Ong","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_15","unstructured":"World Health Organization (2024, November 18). Global Tuberculosis Report 2021. Available online: https:\/\/www.who.int\/publications-detail-redirect\/9789240037021."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102020","DOI":"10.1016\/j.tube.2020.102020","article-title":"Pathology of TB\/COVID-19 co-infection: The phantom menace","volume":"126","author":"Mousquer","year":"2021","journal-title":"Tuberculosis"},{"key":"ref_17","first-page":"117","article-title":"Tuberculosis and COVID-19: A dangerous relationship","volume":"80","author":"Ritacco","year":"2020","journal-title":"Medicina"},{"key":"ref_18","first-page":"59","article-title":"COVID-19 and tuberculosis","volume":"8","author":"Yang","year":"2020","journal-title":"JTIM"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Aiello, A., Najafi-Fard, S., and Goletti, D. (2023). Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-CoV-2: Similarities and differences. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1244556"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Di Bari, V., Gualano, G., Musso, M., Libertone, R., Nisii, C., Ianniello, S., Mosti, S., Mastrobattista, A., Cerva, C., and Bevilacqua, N. (2022). Increased association of pulmonary thromboembolism and tuberculosis during COVID-19 pandemic: Data from an Italian infectious disease referral hospital. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030398"},{"key":"ref_21","unstructured":"Centers for Disease Control and Prevention (CDC) (2024, November 18). Brief Summary of Findings on the Association Between Tuberculosis and Severe COVID-19 Outcomes, Available online: https:\/\/www.cdc.gov\/covid\/media\/pdfs\/science-briefs\/H-TB-Review_Final.pdf."},{"key":"ref_22","unstructured":"WHO (2020). Operational Handbook on Tuberculosis: Module 4: Treatment-Drug-Resistant Tuberculosis Treatment, World Health Organization."},{"key":"ref_23","unstructured":"WHO (2022). Consolidated Guidelines on Tuberculosis: Module 4: Treatment-Drug-Susceptible Tuberculosis Treatment, World Health Organization."},{"key":"ref_24","unstructured":"Global Tuberculosis Network and TB\/COVID-19 Global Study Group (2023). Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. Eur. Respir. J., 62, 2300925."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.radcr.2021.07.079","article-title":"COVID-19 and pulmonary tuberculosis\u2014A diagnostic dilemma","volume":"16","author":"Biswas","year":"2021","journal-title":"Radiol. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Herrera, M.T., Guzm\u00e1n-Beltr\u00e1n, S., Bobadilla, K., Santos-Mendoza, T., Flores-Valdez, M.A., Guti\u00e9rrez-Gonz\u00e1lez, L.H., and Gonz\u00e1lez, Y. (2022). Human pulmonary tuberculosis: Understanding the immune response in the bronchoalveolar system. Biomolecules, 12.","DOI":"10.3390\/biom12081148"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3201\/eid2703.203456","article-title":"Parallels and mutual lessons in tuberculosis and COVID-19 transmission, prevention, and control","volume":"27","author":"Hopewell","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_28","first-page":"54","article-title":"COVID-19 acute respiratory distress syndrome (ARDS): Clinical features differences from typical pre-COVID-19 ARDS","volume":"213","author":"Gibson","year":"2020","journal-title":"MJA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/ATVBAHA.120.314515","article-title":"COVID-19 and respiratory system disorders: Current knowledge, future clinical and translational research questions","volume":"40","author":"Brosnahan","year":"2020","journal-title":"ATVB"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41479-021-00092-9","article-title":"Acute respiratory distress syndrome in COVID-19: Possible mechanisms and therapeutic management","volume":"13","author":"Aslan","year":"2021","journal-title":"Pneumonia"},{"key":"ref_31","first-page":"310","article-title":"Tuberculosis in times of COVID-19","volume":"76","author":"Zimmer","year":"2022","journal-title":"JECH"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"TB\/COVID-19 Global Study Group (2022). Tuberculosis and COVID-19 co-infection: Description of the global cohort. Eur. Respir. J., 59, 2102538.","DOI":"10.1183\/13993003.02538-2021"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sheerin, D., Abhimanyu Wang, X., Johnson, W.E., and Coussens, A. (2020). Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: A patient-level meta-analysis. MedRxiv.","DOI":"10.1101\/2020.11.25.20236646"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/jmv.26740","article-title":"Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses","volume":"93","author":"Sarkar","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100311","DOI":"10.1016\/j.jctube.2022.100311","article-title":"Undernutrition is feeding the tuberculosis pandemic: A perspective","volume":"27","author":"Carwile","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.ijid.2021.02.090","article-title":"Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2","volume":"113","author":"Petrone","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ijid.2023.03.021","article-title":"Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection","volume":"130","author":"Aiello","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3201\/eid2606.200495","article-title":"Identifying and interrupting super spreading events-implications for control of severe acute respiratory syndrome coronavirus 2","volume":"26","author":"Frieden","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_39","first-page":"101031","article-title":"Tuberculosis and COVID-19: A combined global threat to human civilization","volume":"15","author":"Patra","year":"2022","journal-title":"CEGH"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","article-title":"Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects","volume":"27","author":"Visca","year":"2021","journal-title":"Pulmonology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2001708","DOI":"10.1183\/13993003.01708-2020","article-title":"Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital","volume":"56","author":"Stochino","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e149125","DOI":"10.1172\/JCI149125","article-title":"Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection","volume":"131","author":"Riou","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Flores-Lovon, K., Ortiz-Saavedra, B., Cueva-Chica\u00f1a, L.A., Aperrigue-Lira, S., Montes-Madariaga, E.S., Soriano-Moreno, D.R., Bell, B., and Macedo, R. (2022). Immune responses in COVID-19 and tuberculosis coinfection: A scoping review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.992743"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Biciusca, V., Olteanu, M., and Vasile, C.M. (2023). COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144784"},{"key":"ref_45","unstructured":"Prevention CDC (2022). Health Disparities: Race and Hispanic Origin. Provisional Death Counts for Coronavirus Disease 2019."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E964","DOI":"10.1073\/pnas.1711853115","article-title":"Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis","volume":"115","author":"Esmail","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3201\/eid2910.230286","article-title":"Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States","volume":"29","author":"Nabity","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.4269\/ajtmh.20-1156","article-title":"Case Report: Development of Miliary Pulmonary Tuberculosis in a Patient with Peritoneal Tuberculosis after COVID-19 Upper Respiratory Tract Infection","volume":"104","author":"Elziny","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_50","first-page":"10","article-title":"Tuberculosis in the structure of COVID-19 patients comorbidities","volume":"1","author":"Starshinova","year":"2021","journal-title":"Pac. Med. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Vadlamudi, N.K., Basham, C.A., Johnston, J.C., Ahmad Khan, F., Battista Migliori, G., Centis, R., D\u2019Ambrosio, L., Jassat, W., Davies, M.A., and Schwartzman, K. (2023). The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review. PLoS Glob. Public Health, 3.","DOI":"10.1371\/journal.pgph.0002163"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Bostanghadiri, N., Jazi, F.M., Razavi, S., Fattorini, L., and Darban-Sarokhalil, D. (2022). Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.747827"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.pulmoe.2023.05.008","article-title":"Long-term sequelae of TB and COVID-19 co-infection: Prospective cohort evaluation after 1 year","volume":"29","author":"Silva","year":"2023","journal-title":"Pulmonology"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:02Z","timestamp":1760027222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["idr17010011"],"URL":"https:\/\/doi.org\/10.3390\/idr17010011","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}